Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$533M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Micron Technology
MU
|
+$272M |
| 4 |
Eli Lilly
LLY
|
+$232M |
| 5 |
Super Micro Computer
SMCI
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
NVIDIA
NVDA
|
+$413M |
| 3 |
Tesla
TSLA
|
+$403M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Johnson & Johnson
JNJ
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Industrials | 9.62% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
L3Harris
LHX
$54.2B
| $595K | ﹤0.01% |
+2,500
| New | +$577K |
|
2702
Fidelity MSCI Financials Index ETF
FNCL
$2.43B
| $594K | ﹤0.01% |
9,300
+2,900
| +45% | +$178K |
|
|
CTLP
2703
DELISTED
Cantaloupe
CTLP
| $593K | ﹤0.01% |
80,200
-165,900
| -67% | -$1.14M |
|
2704
Goldgroup Mining Inc.
GORO
$212M
| $593K | ﹤0.01% |
1,697,529
+201,139
| +13% | +$79.3K |
|
|
RAPT
2705
DELISTED
RAPT Therapeutics
RAPT
| $592K | ﹤0.01% |
36,825
+11,337
| +44% | +$229K |
|
2706
Vanguard Materials ETF
VAW
$3.06B
| $592K | ﹤0.01% |
2,800
+700
| +33% | +$140K |
|
2707
First Mid Bancshares
FMBH
$1.39B
| $591K | ﹤0.01% |
15,200
+2,200
| +17% | +$83.1K |
|
2708
Cimpress
CMPR
$2.35B
| $590K | ﹤0.01% |
7,200
-10,700
| -60% | -$949K |
|
2709
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.25B
| $590K | ﹤0.01% |
+12,900
| New | +$583K |
|
2710
Pyxis Oncology
PYXS
$184M
| $588K | ﹤0.01% |
160,336
+63,400
| +65% | +$222K |
|
2711
Innospec
IOSP
$2.31B
| $588K | ﹤0.01% |
5,200
-4,000
| -43% | -$466K |
|
|
OPOF
2712
DELISTED
Old Point Financial
OPOF
| $588K | ﹤0.01% |
30,429
+2,300
| +8% | +$40.6K |
|
2713
Champions Oncology
CSBR
$70.6M
| $584K | ﹤0.01% |
119,991
-2,600
| -2% | -$12.2K |
|
|
LFT
2714
Lument Finance Trust
LFT
$34.6M
| $584K | ﹤0.01% |
230,800
+21,878
| +10% | +$55.2K |
|
2715
BOK Financial
BOKF
$8.88B
| $583K | ﹤0.01% |
5,577
-15,900
| -74% | -$1.6M |
|
|
OMGA
2716
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $579K | ﹤0.01% |
474,600
+346,200
| +270% | +$551K |
|
2717
Aldeyra Therapeutics
ALDX
$89.3M
| $579K | ﹤0.01% |
107,400
-395,900
| -79% | -$1.88M |
|
|
SY
2718
So-Young International
SY
$222M
| $579K | ﹤0.01% |
615,528
-16,100
| -3% | -$14.4K |
|
2719
Digimarc Corp
DMRC
$153M
| $578K | ﹤0.01% |
21,500
-200
| -0.9% | -$5.9K |
|
2720
INmune Bio
INMB
$57.7M
| $578K | ﹤0.01% |
+107,200
| New | +$762K |
|
|
LNKB
2721
DELISTED
LINKBANCORP
LNKB
| $577K | ﹤0.01% |
90,000
+65,400
| +266% | +$429K |
|
2722
iShares MSCI Intl Quality Factor ETF
IQLT
$14.3B
| $577K | ﹤0.01% |
+13,900
| New | +$554K |
|
2723
State Street SPDR S&P Semiconductor ETF
XSD
$2.9B
| $577K | ﹤0.01% |
2,400
+1,000
| +71% | +$236K |
|
2724
Virginia National Bankshares
VABK
$254M
| $575K | ﹤0.01% |
13,800
-5,800
| -30% | -$217K |
|
2725
Myomo
MYO
$60.2M
| $574K | ﹤0.01% |
143,100
+8,016
| +6% | +$33.2K |
|
Similar funds
Jim Simons's Q3 2024 Portfolio in Review
As of Q3 2024, Jim Simons held 4,024 positions worth $66.5B, up 13% from $59B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $3.2B of net new capital in Q3 2024, opening 578 new positions and adding to 1,558 existing holdings. Its largest new stake was Micron Technology: 2,604,914 shares worth $270M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $413M trimmed.
- Jim Simons's largest Q3 2024 buy was Micron Technology: 2,604,914 shares worth $270M.
- Jim Simons added most to Microsoft in Q3 2024, an estimated $533M increase.
- Jim Simons's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $413M.
- Jim Simons fully exited Broadcom in Q3 2024, selling an estimated $472M.
- Jim Simons's ten largest holdings make up 11% of its $66.5B portfolio in Q3 2024.
- Jim Simons opened 578 new positions and closed 539 in Q3 2024.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $66.5B.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.